Mackenzie Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,800
Closed -$45.9K – 1568
2026
Q2
$45.9K Buy
+14,800
New +$986K ﹤0.01% 1537

Other funds holding DXCM

Mackenzie Financial's DXCM Position: Q3 2026 in Review

Mackenzie Financial reduced its DexCom (DXCM) stake by 13% in Q3 2026, selling an estimated $2.15M and leaving 171,285 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #545.

Mackenzie Financial first reported a position in DXCM in Q2 2013 and has held it in 54 quarters since. The position peaked at $129M in Q1 2019. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Mackenzie Financial held 171,285 shares of DexCom worth $14.8M as of Q3 2026.
  • Mackenzie Financial sold 25,797 DexCom shares in Q3 2026, an estimated $2.15M.
  • DexCom made up 0.02% of Mackenzie Financial's portfolio in Q3 2026, its #545 holding.
  • Mackenzie Financial first reported a position in DexCom in Q2 2013 and has held it in 54 quarters since.
  • Mackenzie Financial's DexCom position peaked at $129M in Q1 2019.
  • 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.